ADIMMUNE CORPORATION
FDA inspection history in Taichung City, Taiwan, 2018
- 1
- Form 483
Every document, by year
- Form 483
2018: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2018One Form 483, at Taichung City, Taiwan.
Cited most
Across all ADIMMUNE observations on file
- 21 CFR 211.113Control of microbiological contamination3
- 21 CFR 211.110Sampling and testing of in-process materials and drug products2
- 21 CFR 211.160General requirements2
- 21 CFR 211.192Production record review2
- 21 CFR 211.170Reserve samples1
The complete ADIMMUNE file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Taichung City, Taiwan
One Form 483 · 2018 · 14 observations
Latest: Form 483, Jul 30, 2018 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2018-07-30 | 483 Form 483 | Taichung City, Taiwan | 14 | $99 |
Investigators on these documents
FEI number 3008919998 · most recent document Jul 30, 2018
About ADIMMUNE CORPORATION
How many FDA Form 483s has ADIMMUNE CORPORATION received?
FDA Intel has 1 Form 483 on file for ADIMMUNE CORPORATION; the most recent is dated Jul 30, 2018.
When was ADIMMUNE CORPORATION last inspected by FDA?
The most recent FDA inspection document on file for ADIMMUNE CORPORATION is a Form 483 dated Jul 30, 2018, for the site in Taichung City, Taiwan.
What did FDA cite at ADIMMUNE CORPORATION?
The regulations cited most in the observations on file for ADIMMUNE CORPORATION are 21 CFR 211.113 (Control of microbiological contamination), 3 times; 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 2 times; 21 CFR 211.160 (General requirements), 2 times.